NEOTX THERAPEUTICS LTD has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are VELOSBIO INC, BICYCLETX LTD and IMMUNOMIC THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Nathan Asher | 10 |
#2 | Shahar Michal | 7 |
#3 | Shahar Michael | 3 |
#4 | Azulay Meir | 1 |
#5 | Michal Shahar | 1 |
#6 | Asher Nathan | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020230142A1 | Cancer treatment | |
KR20180100412A | Superantigen-mediated cancer immunotherapy promoted by immunity enhancers |